Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Table 3 from Targeting Fibroblast Activation Protein with [177Lu]Lu-FAP-2286 in Patients with Advanced Solid Tumors in the Phase I LuMIERE Trial
  1. Home
  2. Publications
  3. Table 3 from Targeting Fibroblast Activation Protein with [177Lu]Lu-FAP-2286 in Patients with Advanced Solid Tumors in the Phase I LuMIERE Trial

Table 3 from Targeting Fibroblast Activation Protein with [177Lu]Lu-FAP-2286 in Patients with Advanced Solid Tumors in the Phase I LuMIERE Trial

Authors:
  • JMJonathan McConathy
    Jonathan McConathy
  • VKVadim S. Koshkin
    Vadim S. Koshkin
  • YMYusuf Menda
    Yusuf Menda
  • JRJordi Rodon
    Jordi Rodon
  • AGAjit H. Goenka
    Ajit H. Goenka
  • RMRyan H. Moy
    Ryan H. Moy
  • SMSophie Morse
    Sophie Morse
  • ADArnaud Demange
    Arnaud Demange
  • LBLars Blumenstein
    Lars Blumenstein
  • BBBurcu Babaoglan
    Burcu Babaoglan
  • PAPaola Aimone
    Paola Aimone
  • THThomas A. Hope
    Thomas A. Hope

Open Access
Publisher website
Google Scholar
  • 1 September 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.33403119
Abstract
TEAEs occurring in ≥3 patients (all grades) or ≥1 patient (grade ≥3; 177Lu-FAP-2286 safety set, N = 27).
Keywords
  • TARGETING FIBROBLAST
  • FIBROBLAST ACTIVATION
  • ACTIVATION PROTEIN
  • ADVANCED SOLID
  • SOLID TUMORS
  • SAFETY SET
  • LUMIERE TRIAL
  • TRIAL TEAES
  • TEAES OCCURRING
  • TABLE
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.